Nonoperating Income (Expense) of WINDTREE THERAPEUTICS INC /DE/ from 30 Jun 2015 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
WINDTREE THERAPEUTICS INC /DE/ quarterly and annual Nonoperating Income (Expense) in USD history and change rate from 30 Jun 2015 to 30 Sep 2025.
  • WINDTREE THERAPEUTICS INC /DE/ Nonoperating Income (Expense) for the quarter ending 30 Sep 2025 was $11,634,000, a 764% decline year-over-year.
  • WINDTREE THERAPEUTICS INC /DE/ Nonoperating Income (Expense) for the twelve months ending 30 Sep 2025 was $10,005,000, a 163% decline year-over-year.
  • WINDTREE THERAPEUTICS INC /DE/ annual Nonoperating Income (Expense) for 2024 was $24,346,000, a 7856% increase from 2023.
  • WINDTREE THERAPEUTICS INC /DE/ annual Nonoperating Income (Expense) for 2023 was $306,000, a 60% decline from 2022.
  • WINDTREE THERAPEUTICS INC /DE/ annual Nonoperating Income (Expense) for 2022 was $758,000.
Source SEC data
View on sec.gov
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Change (%)
Nonoperating Income (Expense), Annual (USD)
Nonoperating Income (Expense), YoY Annual Change (%)

WINDTREE THERAPEUTICS INC /DE/ Quarterly Nonoperating Income (Expense) (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $10,005,000 $11,634,000 -$13,386,000 -764% 01 Jul 2025 30 Sep 2025 10-Q 19 Nov 2025 2025 Q3
Q2 2025 $3,381,000 $6,647,000 -$6,272,000 -1673% 01 Apr 2025 30 Jun 2025 10-Q 19 Aug 2025 2025 Q2
Q1 2025 $9,653,000 $45,000 -$14,693,000 -100% 01 Jan 2025 31 Mar 2025 10-Q 15 May 2025 2025 Q1
Q4 2024 $24,346,000 $8,231,000 +$8,426,000 01 Oct 2024 31 Dec 2024 10-K 15 Apr 2025 2024 FY
Q3 2024 $15,920,000 $1,752,000 +$1,487,000 +561% 01 Jul 2024 30 Sep 2024 10-Q 19 Nov 2025 2025 Q3
Q2 2024 $14,433,000 $375,000 -$531,000 -340% 01 Apr 2024 30 Jun 2024 10-Q 19 Aug 2025 2025 Q2
Q1 2024 $14,964,000 $14,738,000 +$14,658,000 +18322% 01 Jan 2024 31 Mar 2024 10-Q 15 May 2025 2025 Q1
Q4 2023 $306,000 $195,000 +$52,000 +21% 01 Oct 2023 31 Dec 2023 10-K 15 Apr 2025 2024 FY
Q3 2023 $254,000 $265,000 -$329,000 -55% 01 Jul 2023 30 Sep 2023 10-Q 26 Nov 2024 2024 Q3
Q2 2023 $583,000 $156,000 -$49,000 -24% 01 Apr 2023 30 Jun 2023 10-Q 19 Aug 2024 2024 Q2
Q1 2023 $632,000 $80,000 -$126,000 -61% 01 Jan 2023 31 Mar 2023 10-Q 15 May 2024 2024 Q1
Q4 2022 $758,000 $247,000 -$211,000 -586% 01 Oct 2022 31 Dec 2022 10-K 16 Apr 2024 2023 FY
Q3 2022 $969,000 $594,000 +$660,000 01 Jul 2022 30 Sep 2022 10-Q 09 Nov 2023 2023 Q3
Q2 2022 $309,000 $205,000 +$564,000 01 Apr 2022 30 Jun 2022 10-Q 07 Aug 2023 2023 Q2
Q1 2022 $255,000 $206,000 +$88,000 +75% 01 Jan 2022 31 Mar 2022 10-Q 15 May 2023 2023 Q1
Q4 2021 $343,000 $36,000 +$457,000 +93% 01 Oct 2021 31 Dec 2021 10-K 31 Mar 2023 2022 FY
Q3 2021 $800,000 $66,000 +$249,000 +79% 01 Jul 2021 30 Sep 2021 10-Q 14 Nov 2022 2022 Q3
Q2 2021 $1,049,000 $359,000 +$1,251,000 +78% 01 Apr 2021 30 Jun 2021 10-Q 11 Aug 2022 2022 Q2
Q1 2021 $2,300,000 $118,000 -$51,000 -30% 01 Jan 2021 31 Mar 2021 10-Q 05 May 2022 2022 Q1
Q4 2020 $2,249,000 $493,000 +$2,328,000 +83% 01 Oct 2020 31 Dec 2020 10-K 31 Mar 2022 2021 FY
Q3 2020 $4,577,000 $315,000 -$376,000 -616% 01 Jul 2020 30 Sep 2020 10-Q 10 Nov 2021 2021 Q3
Q2 2020 $4,201,000 $1,610,000 -$1,668,000 -2876% 01 Apr 2020 30 Jun 2020 10-Q 05 Aug 2021 2021 Q2
Q1 2020 $2,533,000 $169,000 +$49,000 +41% 01 Jan 2020 31 Mar 2020 10-Q 13 May 2021 2021 Q1
Q4 2019 $2,582,000 $2,821,000 +$1,370,000 +33% 01 Oct 2019 31 Dec 2019 10-K 03 Apr 2020 2019 FY
Q3 2019 $3,952,000 $61,000 +$520,000 01 Jul 2019 30 Sep 2019 10-Q 16 Nov 2020 2020 Q3
Q2 2019 $4,472,000 $58,000 +$74,000 01 Apr 2019 30 Jun 2019 10-Q 14 Aug 2020 2020 Q2
Q1 2019 $4,546,000 $120,000 -$208,000 -63% 01 Jan 2019 31 Mar 2019 10-Q 13 May 2020 2020 Q1
Q4 2018 $4,338,000 $4,191,000 -$10,162,000 -170% 01 Oct 2018 31 Dec 2018 10-K 03 Apr 2020 2019 FY
Q3 2018 $5,824,000 $459,000 +$190,000 +29% 01 Jul 2018 30 Sep 2018 10-K 03 Apr 2020 2019 FY
Q2 2018 $5,634,000 $16,000 +$596,000 +97% 01 Apr 2018 30 Jun 2018 10-K 03 Apr 2020 2019 FY
Q1 2018 $5,038,000 $328,000 +$936,000 01 Jan 2018 31 Mar 2018 10-K 03 Apr 2020 2019 FY
Q4 2017 $4,102,000 $5,971,000 +$6,205,000 01 Oct 2017 31 Dec 2017 10-K/A 23 Apr 2019 2018 FY
Q3 2017 $2,103,000 $649,000 -$19,000 -3% 01 Jul 2017 30 Sep 2017 10-Q 14 Nov 2018 2018 Q3
Q2 2017 $2,084,000 $612,000 +$19,000 +3% 01 Apr 2017 30 Jun 2017 10-Q 14 Aug 2018 2018 Q2
Q1 2017 $2,103,000 $608,000 -$426,000 -234% 01 Jan 2017 31 Mar 2017 10-Q 21 May 2018 2018 Q1
Q4 2016 $1,677,000 $234,000 01 Oct 2016 31 Dec 2016 10-K 17 Apr 2018 2017 FY
Q3 2016 $630,000 +$12,622,000 +95% 01 Jul 2016 30 Sep 2016 10-Q 14 Nov 2017 2017 Q3
Q2 2016 $631,000 +$727,000 +54% 01 Apr 2016 30 Jun 2016 10-Q 21 Aug 2017 2017 Q2
Q1 2016 $182,000 01 Jan 2016 31 Mar 2016 10-Q 15 May 2017 2017 Q1
Q3 2015 $13,252,000 01 Jul 2015 30 Sep 2015 10-Q 14 Nov 2016 2016 Q3
Q2 2015 $1,358,000 01 Apr 2015 30 Jun 2015 10-Q 10 Aug 2016 2016 Q2

WINDTREE THERAPEUTICS INC /DE/ Annual Nonoperating Income (Expense) (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 $24,346,000 +$24,040,000 +7856% 01 Jan 2024 31 Dec 2024 10-K 15 Apr 2025 2024 FY
2023 $306,000 -$452,000 -60% 01 Jan 2023 31 Dec 2023 10-K 15 Apr 2025 2024 FY
2022 $758,000 +$1,101,000 01 Jan 2022 31 Dec 2022 10-K 16 Apr 2024 2023 FY
2021 $343,000 +$1,906,000 +85% 01 Jan 2021 31 Dec 2021 10-K 31 Mar 2023 2022 FY
2020 $2,249,000 +$333,000 +13% 01 Jan 2020 31 Dec 2020 10-K 31 Mar 2022 2021 FY
2019 $2,582,000 +$1,756,000 +40% 01 Jan 2019 31 Dec 2019 10-K 29 Mar 2021 2020 FY
2018 $4,338,000 -$8,440,000 -206% 01 Jan 2018 31 Dec 2018 10-K 03 Apr 2020 2019 FY
2017 $4,102,000 +$5,779,000 01 Jan 2017 31 Dec 2017 10-K/A 23 Apr 2019 2018 FY
2016 $1,677,000 01 Jan 2016 31 Dec 2016 10-K 17 Apr 2018 2017 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.